249 related articles for article (PubMed ID: 14738805)
1. HIVNET 012 and Petra.
Wilfert CM
Lancet; 2004 Jan; 363(9404):244-5; author reply 245-6. PubMed ID: 14738805
[No Abstract] [Full Text] [Related]
2. HIVNET 012 and Petra.
Cooper E
Lancet; 2004 Jan; 363(9404):244; author reply 245-6. PubMed ID: 14738806
[No Abstract] [Full Text] [Related]
3. HIVNET 012 and Petra.
Hudson CP
Lancet; 2004 Jan; 363(9404):243; author reply 244. PubMed ID: 14738804
[No Abstract] [Full Text] [Related]
4. HIVNET 012 and Petra.
Jackson B; Mmiro F;
Lancet; 2004 Jan; 363(9404):245; author reply 245-6. PubMed ID: 14738808
[No Abstract] [Full Text] [Related]
5. Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis.
Pilger D; Hauser A; Kuecherer C; Mugenyi K; Kabasinguzi R; Somogyi S; Harms G; Kunz A
Antivir Ther; 2011; 16(1):109-13. PubMed ID: 21311114
[TBL] [Abstract][Full Text] [Related]
6. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial.
Jackson JB; Musoke P; Fleming T; Guay LA; Bagenda D; Allen M; Nakabiito C; Sherman J; Bakaki P; Owor M; Ducar C; Deseyve M; Mwatha A; Emel L; Duefield C; Mirochnick M; Fowler MG; Mofenson L; Miotti P; Gigliotti M; Bray D; Mmiro F
Lancet; 2003 Sep; 362(9387):859-68. PubMed ID: 13678973
[TBL] [Abstract][Full Text] [Related]
7. Nevirapine resistance viral mutations after repeat use of nevirapine for prevention of perinatal HIV transmission.
Kuhn L; Sinkala M; Kankasa MP; Kasonde P; Thea DM; Aldrovandi GM
J Acquir Immune Defic Syndr; 2006 Jun; 42(2):260-2. PubMed ID: 16760802
[No Abstract] [Full Text] [Related]
8. [Encouraging study results. HIV from birth on--virostatic drugs can decrease the risk].
MMW Fortschr Med; 1999 Aug; 141(34):61. PubMed ID: 10726137
[No Abstract] [Full Text] [Related]
9. HIV-1 drug resistance and mother-to-child transmission.
Morris L; Pillay C; Gray G; McIntyre J
SADJ; 2001 Dec; 56(12):614-6. PubMed ID: 11887450
[TBL] [Abstract][Full Text] [Related]
10. [Drug resistance of HIV-1 as a result of using nevirapine for chemoprophylaxis of vertical viral transmission from HIV-infected mother to infant].
Kazennova EV
Vopr Virusol; 2009; 54(1):45-8. PubMed ID: 19253732
[TBL] [Abstract][Full Text] [Related]
11. Long-term findings of HIVNET 012: the next steps.
Beckerman KP
Lancet; 2003 Sep; 362(9387):842-3. PubMed ID: 13678965
[No Abstract] [Full Text] [Related]
12. HIVNET nevirapine trials.
Lurie P; Wolfe SM
Lancet; 1999 Nov; 354(9192):1816-7. PubMed ID: 10577660
[No Abstract] [Full Text] [Related]
13. Nevirapine plus zidovudine to prevent mother-to-child transmission of HIV.
Herzmann C; Karcher H
N Engl J Med; 2004 Nov; 351(19):2013-5; author reply 2013-5. PubMed ID: 15525729
[No Abstract] [Full Text] [Related]
14. Establishment of drug-resistant HIV-1 in latent reservoirs.
Dahl V; Palmer S
J Infect Dis; 2009 May; 199(9):1258-60. PubMed ID: 19338473
[No Abstract] [Full Text] [Related]
15. Feeding risk cut for HIV-infected women.
Das P
Lancet; 2003 Jul; 362(9380):300. PubMed ID: 12892984
[No Abstract] [Full Text] [Related]
16. HIV transmission. Allegations raise fears of backlash against AIDS prevention strategy.
Cohen J
Science; 2004 Dec; 306(5705):2168-9. PubMed ID: 15618490
[No Abstract] [Full Text] [Related]
17. Single-dose Nevirapine during pregnancy.
Sax PE
AIDS Clin Care; 1999 Oct; 11(10):84-5. PubMed ID: 11366708
[TBL] [Abstract][Full Text] [Related]
18. Antiretroviral agents--how best to protect infants from HIV and save their mothers from AIDS.
Coovadia H
N Engl J Med; 2004 Jul; 351(3):289-92. PubMed ID: 15247337
[No Abstract] [Full Text] [Related]
19. Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study).
Eshleman SH; Becker-Pergola G; Deseyve M; Guay LA; Mracna M; Fleming T; Cunningham S; Musoke P; Mmiro F; Jackson JB
J Infect Dis; 2001 Oct; 184(7):914-7. PubMed ID: 11509999
[TBL] [Abstract][Full Text] [Related]
20. Scaling the frontier--should traditional birth attendants also be used to provide nevirapine for PMTCT in Uganda?
Kironde S; Lukwago J; Ssenyonga R
Afr Health Sci; 2003 Aug; 3(2):102-3. PubMed ID: 12913802
[No Abstract] [Full Text] [Related]
[Next] [New Search]
